Poster presentations: Clinical 2021

21 posters

Quality of life and fear of disease progression in MS patients with PTSD

Young Investigator
Mariia Andreeva
41
Saint-Petersburg, Russia

Sodium/potassium ratio as a conversion predictor from CIS to MS

Young Investigator
Marlene Arbeu-Reyes
11
Mineral de la Reforma, Mexico

Effect of Teriflunomide on Neurofilament Light Chain Levels in Children with RMS

Brenda Banwell
51
Philadelphia, United States

Ph1 OLE and imaging data for ATA188, an allogeneic EBV-targeted MS immunotherapy

Amit Bar-Or
30
Pennsylvania, United States

Peripheral neuropathy as potential side effect of teriflunomide

Young Investigator
Serena Borrelli
5
Brussels, Belgium

Real world experience with Ocrelizumab in patients with PPMS: German NTD Registry

Stefan Braune
69
Grenzach-Wyhlen, Germany

Patient-Reported Outcomes & their Interconnectivity in Multiple Sclerosis

Giampaolo Brichetto
24
Genova, Italy

Humoral immune response to SARS-CoV2 vaccines in multiple sclerosis and controls

Young Investigator
Gabriel Bsteh
32
Vienna, Austria

Long-term disability outcomes in multiple sclerosis: a 25-year follow-up study

Young Investigator
Sena Destan Bunul
77
Kocaeli, Turkey

NICARA: Clinically feasible detection of structural connectivity changes in MS

Markus Butz-Ostendorf
52
Planegg, Germany

Frequency of New Silent MRI lesions in MOGAD and AQP4-NMOSD

Young Investigator
Valentina Camera
49
Oxford, United Kingdom

CONFIDENCE: Real-world effectiveness of ocrelizumab in relapsing MS over 18 months

Young Investigator
Julius Eggebrecht
25
Grenzach-Wyhlen, Germany

Prevalence of PTSD in Russian population of MS patients

Young Investigator
Ivan Kalinin
40
Saint-Petersburg, Russia

Factors affecting cognitive impairment in Japanese patients with multiple sclerosis

Masaaki Niino
7
Sapporo, Japan

Quantify upper limb impairment in the ADL in people with Multiple Sclerosis

Young Investigator
Marco Pisa
14
Milan, Italy

Exercise therapy as supplemental treatment in early multiple sclerosis: a RCT

Winner Young Investigator Award
Young Investigator
Morten Riemenschneider
28
Aarhus, Denmark

Konectomâ„¢ cognitive processing speed testing and the influence of reaction time

Matt Scaramozza
35
Cambridge, United States

DigiToms Study: preliminary findings on Konectomâ„¢ digital outcome assessments in MS

Matt Scaramozza
50
Cambridge, United States

Establishment of a ddPCR method for detecting Epstein-Barr Virus in MS samples

Tassja Spindler
59
Thousand Oaks, United States

The impact of COVID-19 on patients with neuromyelitis optica beyond infection risk

Young Investigator
Hexiang Yin
65
Beijing, China

The epidemiology of COVID-19 and MS characteristics in a national sample in China

Yao Zhang
67
Beijing, China